Acutus Medical (AFIB) Competitors $0.05 0.00 (0.00%) As of 03/27/2025 10:59 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsTrendsBuy This Stock AFIB vs. CHEK, AMIX, NUWE, SINT, CTCX, NAOV, HSCS, TNON, GCTK, and BBLGShould you be buying Acutus Medical stock or one of its competitors? The main competitors of Acutus Medical include Check-Cap (CHEK), Autonomix Medical (AMIX), Nuwellis (NUWE), Sintx Technologies (SINT), Carmell (CTCX), NanoVibronix (NAOV), Heart Test Laboratories (HSCS), Tenon Medical (TNON), GlucoTrack (GCTK), and Bone Biologics (BBLG). These companies are all part of the "medical equipment" industry. Acutus Medical vs. Check-Cap Autonomix Medical Nuwellis Sintx Technologies Carmell NanoVibronix Heart Test Laboratories Tenon Medical GlucoTrack Bone Biologics Acutus Medical (NASDAQ:AFIB) and Check-Cap (NASDAQ:CHEK) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, dividends, risk, earnings, analyst recommendations, valuation and community ranking. Which has stronger earnings and valuation, AFIB or CHEK? Check-Cap has lower revenue, but higher earnings than Acutus Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAcutus Medical$7.16M0.22-$81.66MN/AN/ACheck-CapN/AN/A-$17.57M-$3.00-0.28 Is AFIB or CHEK more profitable? Check-Cap has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Check-Cap's return on equity of 0.00% beat Acutus Medical's return on equity.Company Net Margins Return on Equity Return on Assets Acutus Medical-272.74% -311.64% -11.57% Check-Cap N/A N/A N/A Does the media prefer AFIB or CHEK? In the previous week, Check-Cap had 1 more articles in the media than Acutus Medical. MarketBeat recorded 3 mentions for Check-Cap and 2 mentions for Acutus Medical. Check-Cap's average media sentiment score of 0.96 beat Acutus Medical's score of 0.48 indicating that Check-Cap is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Acutus Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Check-Cap 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community prefer AFIB or CHEK? Check-Cap received 358 more outperform votes than Acutus Medical when rated by MarketBeat users. Likewise, 61.46% of users gave Check-Cap an outperform vote while only 32.43% of users gave Acutus Medical an outperform vote. CompanyUnderperformOutperformAcutus MedicalOutperform Votes1232.43% Underperform Votes2567.57% Check-CapOutperform Votes37061.46% Underperform Votes23238.54% Do insiders & institutionals hold more shares of AFIB or CHEK? 56.9% of Acutus Medical shares are held by institutional investors. Comparatively, 1.1% of Check-Cap shares are held by institutional investors. 5.2% of Acutus Medical shares are held by company insiders. Comparatively, 0.5% of Check-Cap shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has more risk and volatility, AFIB or CHEK? Acutus Medical has a beta of -0.14, indicating that its stock price is 114% less volatile than the S&P 500. Comparatively, Check-Cap has a beta of 0.19, indicating that its stock price is 81% less volatile than the S&P 500. SummaryCheck-Cap beats Acutus Medical on 9 of the 12 factors compared between the two stocks. Remove Ads Get Acutus Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AFIB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AFIB vs. The Competition Export to ExcelMetricAcutus MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.55M$4.42B$5.65B$8.06BDividend YieldN/A32.64%4.57%4.01%P/E RatioN/A28.8723.1419.03Price / Sales0.2250.00385.7893.17Price / CashN/A51.0838.1634.64Price / Book-1.736.146.934.33Net Income-$81.66M$67.64M$3.20B$247.06M7 Day PerformanceN/A-2.07%-2.30%-0.37%1 Month PerformanceN/A-0.48%2.86%-3.85%1 Year PerformanceN/A12.88%10.66%1.27% Acutus Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AFIBAcutus MedicalN/A$0.05flatN/A-73.8%$1.55M$7.16M0.00340Upcoming EarningsGap DownCHEKCheck-Cap1.0929 of 5 stars$0.91+3.0%N/A-69.4%$5.30MN/A-0.3080Analyst ForecastShort Interest ↓AMIXAutonomix Medical3.3878 of 5 stars$2.03+2.0%$28.00+1,279.3%-96.6%$5MN/A-0.161Short Interest ↓Gap UpNUWENuwellis3.6635 of 5 stars$1.14+0.9%$17.00+1,391.2%-92.8%$4.99M$8.74M-0.0170Short Interest ↓SINTSintx Technologies1.0881 of 5 stars$2.89-3.7%N/A-70.8%$3.88M$1.64M-0.0640Short Interest ↓Gap DownCTCXCarmell1.1393 of 5 stars$0.18-4.1%N/A-93.4%$3.81M$32,839.000.0014Gap DownNAOVNanoVibronix0.7434 of 5 stars$4.25-3.2%N/A-61.3%$3.37M$3.29M-3.4620Short Interest ↓Gap DownHSCSHeart Test Laboratories2.8231 of 5 stars$2.96+1.7%$13.00+339.2%-75.7%$3.20M$14,700.00-0.3710TNONTenon Medical1.6353 of 5 stars$0.98-2.2%$5.50+462.3%+211.0%$3.07M$3.32M-0.048Short Interest ↑High Trading VolumeGCTKGlucoTrack1.8248 of 5 stars$0.27-9.5%N/A-99.3%$2.81MN/A0.005Short Interest ↓Gap DownHigh Trading VolumeBBLGBone Biologics1.2472 of 5 stars$0.85-3.4%N/A-58.7%$2.78MN/A0.002Short Interest ↓ Remove Ads Related Companies and Tools Related Companies CHEK Competitors AMIX Competitors NUWE Competitors SINT Competitors CTCX Competitors NAOV Competitors HSCS Competitors TNON Competitors GCTK Competitors BBLG Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AFIB) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acutus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acutus Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
